Insulin resistance in chronic kidney disease: Its clinical characteristics and prognostic significance;Resistencia a la insulina en la enfermedad renal crónica: Características clínicas asociadas y significado pronóstico

Nefrologia

Volumn 30, Issue 6, 2010, Pages 661-668

  Caravaca, F ^a   Cerezo, I ^a   Macias R ^a   De Vinuesa, E García ^a   Del Viejo, C Martínez ^a   Villa, J ^a   Gallardo, R Martínez ^a   Ferreira, F ^a   Hernandez Gallego R ^a  

^a HOSPITAL INFANTA CRISTINA   (Spain)

Author keywords

Cardiovascular risk; Chronic kidney disease; Insulin resistance; Mortality; Progression renal insufficiency

Indexed keywords

EID: 78649968376     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2010.Aug.10491     Document Type: Article

References (35)

1. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996;97:2601-10.
2. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996;334:374-81.
3. Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest 2000;106:453-8.
4. McFarlane SI, Banerji M, Sowers JR. Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab 2001;86:713-8.
5. Eidemak I, Feldt-Rasmussen B, Kanstrup IL, Nielsen SL, Schmitz O, Strandgaard S. Insulin resistance and hyperinsulinemia in mild to moderate progressive chronic renal failure and its association with aerobic work capacity. Diabetologia 1995;38:565-72.
6. Fliser D, Pacini G, Engelleiter R, Kautzky-Willer A, Prager R, Franek E, et al. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 1998;53:1343-7.
7. Becker B, Kronenberg F, Kielstein JT, Haller H, Morath C, Ritz E, et al., MMKD Study Group. Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol 2005;16:1091-8.
8. Lorenzo C, Nath SD, Hanley AJ, Abboud HE, Haffner SM. Relation of low glomerular filtration rate to metabolic disorders in individuals without diabetes and with normoalbuminuria. Clin J Am Soc Nephrol 2008;3:783-9.
9. DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J. Insulin resistance in uremia. J Clin Invest 1981;67:563-8.
10. Alvestrand A, Mujagic M, Wajngot A, Efendic S. Glucose intolerance in uremic patients. The relative contributions of impaired beta-cell function and insulin resistance. Clin Nephrol 1989;31:175-83.
11. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998;9(Supl 12):S16-S23.
12. Schiffri EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007;116:85-97.
13. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple J. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003;63:793-808.
14. Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, et al. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 2002;13:1894-900.
15. Menon V, Li L, Wang X, Greene T, Balakrishnan V, Madero M, et al. Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol 2006;17:2599-606.
16. Takenaka T, Kanno Y, Ohno Y, Suzuki H. Key role of insulin resistance in vascular injury among hemodialysis patients. Metabolism 2007;56:153-9.
17. Davies SJ, Phillips L, Naish PF, Russell GI. Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival. Nephrol Dial Transplant 2002;17:1085-92.
18. Bergström J, Fürst P, Alvestrand A, Lindholm B. Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney Int 1993;44:1048-57.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment. Diabetologia 1985;28:412-9.
20. Kanauchi M, Akai Y, Hashimoto T. Validation of simple indices to assess insulin sensitivity and pancreatic beta-cell function in patients with renal dysfunction. Nephron 2002;92:713-5.
21. Abrass CK. Overview. Obesity: what does it have to do with kidney disease? J Am Soc Nephrol 2004;15:2768-72.
22. Bagby SP. Obesity-initiated metabolic syndrome and the kidney: A recipe for chronic kidney disease? J Am Soc Nephrol 2004;15:2775-91.
23. Schelling JR, Sedor JR. The metabolic syndrome as a risk factor for chronic kidney disease: More than a fat chance? J Am Soc Nephrol 2004;15:2773-4.
24. Kwan BCH, Kronenberg F, Beddhu S, Cheung AK. Lipoprotein metabolism and lipid management in chronic kidney disease. J Am Soc Nephrol 2007;18:1246-61.
25. Friedman AN, Fadem SZ. Reassessment of albumin as a nutritional marker in kidney disease. J Am Soc Nephrol 2010;21:223-30.
26. Siew ED, Pupim LB, Majchrzak KM, Shintani A, Flakoll PJ, Ikizler TA. Insulin resistance is associated with skeletal muscle protein breakdown in non-diabetic chronic hemodialysis patients. Kidney Int 2007;71:146-52.
27. Gin H, Aparicio M, Potaux L, Merville P, Combe C, De Precigout V, et al. Low-protein, low-phosphorus diet and tissue insulin sensitivity in insulin-dependent diabetic patients with chronic renal failure. Nephron 1991;57:411-5.
28. Gin H, Combe C, Rigalleau V, Delafaye C, Aparicio M, Aubertin J. Effects of a low-protein, low phosphorus diet on metabolic insulin clearance in patients with chronic renal failure. Am J Clin Nutr 1994;59:663-6.
29. Rigalleau V, Blanchetier V, Combe C, Guillot C, Deleris G, Aubertin J, et al. A low-protein diet improves insulin sensitivity of endogenous glucose production in predialytic uremic patients. Am J Clin Nutr 1997;65:1512-6.
30. DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest 1975;55:845-55.
31. Allón M, Rodríguez M, Llach F. Insulin in the acute renal adaptation to dietary phosphate restriction in the rat. Kidney Int 1990;37:14-20.
32. Gunputalli J, Rogers A, Bourke E. Effect of insulin on renal phosphorus handling in the rat: Interaction with PTH and nicotinamide. Am J Physiol 1985; 249:F610-F618.
33. El-Atat FA, Stas SN, McFarlane SI, Sowers JR. The relationship between hyperinsulinemia, hypertension and progressive renal disease. J Am Soc Nephrol 2004;15:2816-27.
34. Kaartinen K, Syrjanen J, Porsti I, Harmoinen A, Pasternack A, Huhtala H, et al. Insulin resistance and the progression of IgA glomerulonephritis. Nephrol Dial Transplant 2007;22:778-83.
35. Oterdoom LH, De Vries AP, Gansevoort RT, De Jong PE, Gans RO, Bakker SJ. Fasting insulin modifies the relation between age and renal function. Nephrol Dial Transplant 2007;22:1587-92.